Year To Quarter End Consolidated Statement Of Income

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7328181

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
63,348,000,000 JPY
63,348,000,000 JPY
10,511,000,000 JPY
75,579,000,000 JPY
4,915,000,000 JPY
983,000,000 JPY
79,758,000,000 JPY
56,243,000,000 JPY
70,686,000,000 JPY
3,275,000,000 JPY
56,243,000,000 JPY
10,342,000,000 JPY
824,000,000 JPY
67,493,000,000 JPY
Cost of sales
30,469,000,000 JPY
38,238,000,000 JPY
27,569,000,000 JPY
35,118,000,000 JPY
Gross profit (loss)
32,878,000,000 JPY
37,341,000,000 JPY
28,674,000,000 JPY
32,374,000,000 JPY
Selling, general and administrative expenses
Depreciation
2,910,000,000 JPY
2,917,000,000 JPY
2,660,000,000 JPY
2,674,000,000 JPY
Selling, general and administrative expenses
30,251,000,000 JPY
33,324,000,000 JPY
30,881,000,000 JPY
33,503,000,000 JPY
Operating profit (loss)
2,627,000,000 JPY
2,627,000,000 JPY
1,064,000,000 JPY
4,017,000,000 JPY
261,000,000 JPY
81,000,000 JPY
4,035,000,000 JPY
-2,207,000,000 JPY
-1,225,000,000 JPY
78,000,000 JPY
-2,207,000,000 JPY
881,000,000 JPY
21,000,000 JPY
-1,129,000,000 JPY
Non-operating income
Interest income
21,000,000 JPY
23,000,000 JPY
Dividend income
1,297,000,000 JPY
1,379,000,000 JPY
Gain on sale of securities
585,000,000 JPY
585,000,000 JPY
50,000,000 JPY
50,000,000 JPY
Non-operating income
2,396,000,000 JPY
2,329,000,000 JPY
1,916,000,000 JPY
1,837,000,000 JPY
Non-operating expenses
Interest expenses
10,000,000 JPY
18,000,000 JPY
12,000,000 JPY
20,000,000 JPY
Non-operating expenses
248,000,000 JPY
203,000,000 JPY
157,000,000 JPY
109,000,000 JPY
Ordinary profit (loss)
4,776,000,000 JPY
6,142,000,000 JPY
-448,000,000 JPY
598,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
121,000,000 JPY
121,000,000 JPY
67,000,000 JPY
67,000,000 JPY
Extraordinary income
8,349,000,000 JPY
8,349,000,000 JPY
13,086,000,000 JPY
13,086,000,000 JPY
Extraordinary losses
Extraordinary losses
43,000,000 JPY
43,000,000 JPY
4,000,000 JPY
4,000,000 JPY
Profit (loss) before income taxes
13,082,000,000 JPY
14,449,000,000 JPY
12,633,000,000 JPY
13,680,000,000 JPY
Income taxes - current
2,819,000,000 JPY
3,263,000,000 JPY
1,845,000,000 JPY
2,113,000,000 JPY
Income taxes - deferred
-44,000,000 JPY
-104,000,000 JPY
877,000,000 JPY
932,000,000 JPY
Income taxes
2,774,000,000 JPY
3,159,000,000 JPY
2,722,000,000 JPY
3,046,000,000 JPY
Profit (loss)
10,307,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
11,289,000,000 JPY
10,307,000,000 JPY
9,910,000,000 JPY
9,910,000,000 JPY
9,910,000,000 JPY
9,910,000,000 JPY
10,634,000,000 JPY
Profit attributable to
Profit (loss) attributable to non-controlling interests
128,000,000 JPY
105,000,000 JPY
Profit (loss) attributable to owners of parent
11,160,000,000 JPY
11,160,000,000 JPY
11,160,000,000 JPY
10,528,000,000 JPY
10,528,000,000 JPY
10,528,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
22,398,000,000 JPY
-14,688,000,000 JPY
Remeasurements of defined benefit plans, net of tax
2,357,000,000 JPY
-174,000,000 JPY
Other comprehensive income
24,755,000,000 JPY
-14,863,000,000 JPY
Comprehensive income
36,044,000,000 JPY
-4,229,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
35,851,000,000 JPY
-4,349,000,000 JPY
Comprehensive income attributable to non-controlling interests
192,000,000 JPY
120,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.